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 Higher incidence of cancer diagnosis, death, and psychosocial distress are present among 
traditionally underserved and marginalized populations in the United States. High mortality rates 
and physical pain are associated with lung cancer and head and neck cancer due to less favorable 
treatment outcomes and later stage diagnosis that is typical with these types of cancer, and these 
high rates are observed more often in populations of patients who are identified as underserved. 
These physical symptoms are coupled with increased psychological distress throughout the 
course of treatment for underserved cancer patients. Symptoms of anxiety and depression are 
common and often are associated with poorer treatment adherence and outcomes.  
 The current study seeks to validate the Patient Reported Outcomes Measurement 
Information System (PROMIS) measures in a sample of underserved lung cancer and head and 
neck cancer patients. Data was collected from 92 respondents who were recently diagnosed with 
lung cancer and/or head and neck cancer and were identified as underserved either by indicating 
that their household income fell below the Federal poverty line or by indicating that they were 
uninsured or underinsured. Responses on the PROMIS measures anxiety and depression 
subscales were correlated with responses on other measures of anxiety and depression in order to 
establish convergent validity. Predictive validity was determined by exploring the ability of the 




PROMIS anxiety and depression responses were analyzed with responses on a measure of 
quality of life to establish discriminant validity.  
The results of this study imply that the PROMIS measures are valid and reliable in a 
sample of underserved lung cancer and head and neck cancer patients. In doing so, the study 
hopes to increase the ease of understanding the psychological distress experienced by 









ABSTRACT .................................................................................................................................... ii 
INTRODUCTION .......................................................................................................................... 1 
Psychological Factors .................................................................................................................. 4 
Depression ................................................................................................................................... 6 
Measures of Depression .............................................................................................................. 7 
Anxiety ...................................................................................................................................... 11 
Measures of Anxiety ................................................................................................................. 13 
Quality of Life ........................................................................................................................... 15 
Measures of Quality of Life ...................................................................................................... 16 
PROMIS Measures .................................................................................................................... 17 
Current Study ............................................................................................................................ 19 
METHODS ................................................................................................................................... 20 
Procedures ................................................................................................................................. 20 
Participants ................................................................................................................................ 21 
Power Analysis .......................................................................................................................... 21 
Measures.................................................................................................................................... 22 
RESULTS ..................................................................................................................................... 25 
DISCUSSION ............................................................................................................................... 28 
PROMIS Measures .................................................................................................................... 28 
Implications and Contributions ................................................................................................. 30 
Future Directions ....................................................................................................................... 31 
TABLES ....................................................................................................................................... 33 
REFERENCES ............................................................................................................................. 39 








Health disparities in the United States, specifically in relation to underserved populations 
continue to exist. Health disparities refer to the differences in health outcomes amongst various 
groups, usually linked to social, economic, or environmental disadvantage (U.S. Department of 
Health and Human Services [HHS], 2011). For the current study, the term undeserved will be 
utilized to denote those individuals who are socially disadvantaged and have low access to 
medical resources. Individuals were determined to be underserved if their household income fell 
below the Federal poverty line and/or if they did not have insurance coverage or identified as 
underinsured.  
Higher rates of cancer diagnosis, death, and psychosocial distress are present among 
underserved groups in the United States such as those who are underinsured or those who do not 
speak English as a primary language (Zonderman, Ejiogu, Norbeck, & Evans, 2014). 
Additionally, low socioeconomic status (SES) has been correlated with high comorbidity of 
chronic illness in cancer patients and higher rates of death in comparison to higher SES patients 
with similar cancer diagnosis (Louwman et al., 2010). While cancer is one of the most prevalent 
diagnoses in the United States, with over 21 distinct types, lung cancer (LC) is the primary cause 
of cancer death of men and women in the United States (American Cancer Society [ACS], 2015). 
High rates of death from LC can be attributed to later-stage diagnosis resulting in less treatment 
options and less favorable outcomes (Siegel, et al., 2012, Ries, et al., 2007). Additionally, many 
patients with who are diagnosed with LC either present initially with head-and-neck cancer 
(HNC) or are at risk for developing HNC later in their illness (Center for Disease Control 




often lead to long-term physical consequences and/or disfigurement (Frampton, 2001). Surgery, 
radiation, and chemotherapy are common modes of therapy for cancer and can impact everyday 
functions such as breathing, speaking, and swallowing, negatively impacting quality of life 
(Carper, Fleishmen, McGuire, 2004).  
Underserved cancer patients may experience higher levels of distress and impact from 
their illnesses than other patients with greater resources. Barriers in access to quality care include 
economic, social, and educational barriers; combined with premorbid medical conditions, 
comorbid mental health conditions, and later stage diagnosis contribute to cancer disparities as 
well (Bowen, Alfano, McGregor, Kuniyuki, Bernstein, Meeske, & Ganz, 2007; Fagundes, Jones, 
Vichaya, Lu, Cleeland, 2014). For HNC and LC patients, later stage diagnosis is highly linked to 
SES and access to insurance (Greenwald et al., 1998). Additionally, for LC patients, low SES 
was found to be a poorer prognostic factor than late stage diagnosis or lack of treatment options 
(Ou et al., 2008).  
Past research indicates that mental health disparities exist for underserved patients with 
HNC and LC. Higher rates of depression, anxiety, and overall mental distress have been 
observed in low SES patients (Fagundes et al., 2014). Due to a lack of resources, systematic 
marginalization, and other life circumstances, correlates of depression and depressive disorders 
are likely more common among underserved populations of patients (Miranda, et al., 2003; 
Ashing-Giwa & Lim, 2009; Chong, Reinschmidt, & Moreno, 2010; Holden, Ramirez, & Gallion, 
2014). The social determinants for these disparities have been explored; however, measurement 
of these underlying psychological mechanisms vary from study to study. A meta-analysis by 
Luckett et al. (2011) was conducted to determine the psychosocial concerns and psychological 




socioeconomic statuses. The authors found that in the studies reviewed, patients who identified 
as a cultural minority experienced the most mental health disparities in emotional distress, as 
well as areas of emotional coping, social functioning and quality of life, compared to other 
groups included in the study. The authors reviewed 21 articles that included 13 different 
measures of anxiety, depression, and quality of life. The authors indicated that the heterogeneity 
of the measures and the information provided from these studies made cross-comparison 
difficult, creating challenges in drawing conclusions about the experiences of the patients in 
these studies.  
In order to compare mental health conditions among HNC and LC patients who identify 
as underserved, standard measures must be established first and then validated within these 
populations. Additionally, some of the measures in Luckett et al. (2011) study did not correlate 
with diagnostic criteria for either depression or anxiety but simply assessed for symptoms of 
those disorders. More standard measures that align with diagnostic criteria for psychological 
disorders would allow for easier detection and diagnosis as well as comparison across groups. 
The Patient-Reported Outcomes Measurement Information System (PROMIS) was developed by 
the National Institute of Health as a way to measure diagnostic symptoms and health concepts 
efficiently and interpretably across chronic health conditions (Cella, et al., 2007). PROMIS 
includes domains of both mental and physical health and the symptoms included in these 
measures are consistent with diagnostic criteria for psychological disorders and PROMIS was 
designed to facilitate easy screening for mental health conditions without including 
symptomology that is related to the chronic illness that patients experience.  
In the current study, a battery of psychological measures were administered to a 




the Federal poverty line, uninsured, or underinsured. Participants were recruited for the study 
from four hospitals in the Northern Colorado area. Surveys were available in English or in 
Spanish and were administered online, over the phone, and mailed paper and pencil versions. 
The set of measures assessed psychological outcomes that effect HNC and LC patients’ levels of 
depression, anxiety, and quality of life. This study provides support for the PROMIS measures 
validity and reliability in assessing the psychological constructs that impact underserved LC and 
HNC patients. 
Psychological Factors 
Some major psychological domains impacted by the diagnosis and treatment of LC and 
HNC are mood and quality of life. Both depression and anxiety symptoms have been observed to 
surge during and post treatment for LC and HNC, indicating that this is an area of concern for 
patients and providers seeking to improve patients quality of life (Duffy, et al., 2007; Alfano & 
Rowland, 2006; Apollo, Crew, Campbell, Greenlee, Jacobson, Grann, & Hershman, 2007; 
Ashing-Giwa, Rosales, Lai, Weitzel, 2013). The symptoms of anxiety or depression must cause 
distress and interfere with normal functioning in order to be considered clinically significant 
(APA, 2013) and can be measured by self-report or formal diagnosis by mental health 
professionals. Quality of life (QoL) is a more broad assessment of overall functioning in a 
variety of life spheres such as physical, social, and emotional functioning. Health Related 
Quality of Life (HRQoL) examines the same life spheres as they are impacted by health status. 
QoL is based on self-report and allows researchers a more complete look at the experience of LC 
and HNC patients when measured as it includes a variety of domains (Levine, Yoo, & Aviv, 
2015). Mood and QoL variables fluctuate throughout the journey of a HNC and LC diagnosis 




image, and clinical symptoms (Hammerlid, Silander, Hornestam, Sullivan, 2001; Zeller, 2006; 
DiSipio, Hayes, Battistutta, Newman, & Janda, 2011).  High levels of distress also come from 
fear of reoccurrence and high pain and suffering due to treatment (Zeller, 2006). High rates of 
suicidality have been observed in this population as well, pointing to psychological distress and 
low coping ability (Sarna, et al., 2002). As such, integrative models like the TMSC which is 
subjective and individually focused, are needed to understand LC and HNC and their impact on 
patients due to the distinct nature of each person’s experience. Research investigating which 
psychosocial variables predict adjustment in cancer patients has determined that depression, 
anxiety, and QoL predicted treatment outcomes consistently and significantly (DiSipio, et al., 
2011; Luckett, et al., 2011; Weinberger, Forrester, Markov, Chism, & Kunkel, 2010).  
The primary psychological factors in this study were anxiety and depression, and 
measures assessing patient’s self-reported quality of life were also included to establish validity 
for the measures of interest in this study. Though a wealth of evidence points to the existence of 
health disparities between populations of underserved cancer patients and higher SES patients 
(Apollo, et al. 2007; Ashing-Giwa & Lim, 2009; Ashing-Giwa, et al., 2013; Louwman et al., 
2008), little research has addressed whether psychological factors further contribute to these 
health disparities. To explore the rates of psychological distress and its impacts in underserved 
LC and HNC patients, valid and reliable instruments need to be established. The current study 
focuses on establishing the validity and reliability of the PROMIS measures in HNC and LC 
patients who are considered underserved. Establishing these measures as reliable and valid will 
support research of the extent to which psychological issues are contributing to health disparities 





Depressive symptoms include feelings of sadness, emptiness, hopelessness, diminished 
interest or pleasure in activities, disturbances in sleeping and eating patterns, fatigue, and suicidal 
ideation. (APA, 2013). Studies indicate that half of HNC patients experience depressive 
symptoms and between 11% and 44% of LC patients show depressive symptoms (Duffy et al., 
2007; Alfano & Rowland, 2006). It is challenging to assess actual rates of depression among this 
population across studies due to discrepancies in measurement (Navari, et al., 2008; Weinberger, 
et al., 2010) in which some studies use measures that capture clinical depression symptoms while 
other assess for indicators of distress or dysthymia. Depressive symptoms have been correlated 
with higher reporting of physical pain and decreased functional wellbeing, as well as increased 
rates of anxiety (Ell, et al. 2005, Weinberger et al., 2010; Elsheshtawy et al., 2010) which are 
also common reactions to cancer diagnosis and treatment in general. This overlap makes it 
challenging to parse out which symptoms are related to clinical depression, which should be 
treated with therapeutic intervention or medication, and which are appropriate distress levels 
related to being a cancer patient. There is mixed evidence on whether type of treatment is 
correlated with depression rates, however a study of patients with early stage breast cancer 
indicated that the longer term distress a treatment causes, the more depressive symptoms the 
patient is likely to endorse (Navari, Brenner, & Wilson, 2008). In this study, patients undergoing 
chemotherapy and antiestrogen treatments had higher rates of depression than those with faster 
acting interventions. Other studies suggest that education level, social support, and marital status 
predict depressive symptoms among women with breast cancer (Ell, et al., 2005; Tojal & Costa, 




A recent study found that low SES patients with LC experienced higher levels of distress 
compared to high SES patients with similar stage diagnosis (Fagundes, Jones, Vichaya, Lu, & 
Cleeland, 2014). A relationship has been found between barriers to treatment and depressive 
symptoms in underserved patients (Luckett et al., 2011; Ell, et al., 2005; Chong, Reinschmidt, & 
Moreno, 2010). Barriers to care, such as lack of understanding of treatment, economic stress, 
lack of insurance, adverse attitudes towards medicine, and low utilization of medical benefits 
were highly correlated with depressive symptoms in underserved populations. These barriers can 
lead to negative outcomes such as noncompliance with treatment, low quality of life, and loss of 
life (Chong, Reinschmidt, & Moreno, 2010, Ashing-Giwa et al., 2013; Zonderman, et al., 2014). 
Failure to recognize and treat depression in cancer patients further promote these negative 
outcomes including decreased quality of life and survival rates (Somerset et al., 2004; Tojal & 
Costa, 2015) highlighting the importance of accurately measuring and diagnosing clinical 
depression (Navari et al., 2008). 
Measures of Depression 
The Hospital Anxiety and Depression Scale (HADS) and the Center for Epidemiological 
Studies Depression Scale (CES-D) have been the most widely used with cancer patients to assess 
depression symptoms and have been found to be sensitive to depression, cost effective, and have 
strong psychometric properties (Mitchell, Meader, & Symonds, 2010; Luckett et al., 2010; 
Stafford, et al., 2013). The HADS has two subscales, the HADS-D for depression and the 
HADS-A for anxiety and combined contains fourteen items (Zigmond & Snaith, 1983).  Because 
of its intentioned use in hospital settings, the items on the HADS avoid somatic symptomology 
to parse out psychological distress beyond physical symptoms. In samples of somatic, 




depression symptoms using a cutoff score of 8 but is not directly related to DSM diagnosis of 
Major Depressive Disorder criteria (Bjellen, Dahl, Haug, & Neckelman, 2002).  
In cancer patients specifically, the HADS-D has been found to be a useful screening tool, 
however, the sensitivity for diagnostic purposes is low, between 65-72% sensitivity and concerns 
about the length of the measure and its specificity have been raised (Mitchell, Meader, & 
Symonds, 2010). Additionally, questions have been raised regarding the emphasis on anhedonia 
as an indicator of depression in the HADS and whether or not this is useful for detection of 
depression (Luckett et al., 2010). The Spanish version of the HADS has been evaluated in 
medical settings and found to have high internal consistency (α=0.86) and high concurrent 
validity with other measures of depression (Quintana et al., 2003). While the HADS has been 
widely used, strict and standard cutoffs or percentages for diagnosis have not been established or 
enforced, leading to lack of clarity in determination of clinical cutoffs (Luckett, et al., 2010). 
The CES-D is a 20 item self-report instrument derived from other screening instruments 
and contains questions regarding key symptoms of depression (Schroevers, Sanderman, Van 
Sonderen, & Ranchor, 2000). While the items on the CES-D seem to reliably detect symptoms of 
depression (α = 0.88-0.91), the validity of detecting clinically significant depression is 
questioned due to the measures tendency to capture cancer related somatic distress also 
(Schroevers, et al., 2000). Additionally, the CES-D requires 20 items to assess only one construct 
while other measures are shorter and more valid (Luckett et al., 2010). Other researchers have 
utilized the Zung Self-Rating Depression Scale (SDS or BZSDS for the brief version) which has 
been found to be useful for screening for depression symptoms but is also not related to DSM 




The Profile of Mood States (POMS) is an assessment used to look at mood states and has 
been used to assess for depression in cancer patients reliably (α= 0.63 – 0.91) however not an 
accurate tool for diagnosis because it captures transient and fluctuating moods rather than 
pervasive symptomology (McNair, et al. 1971; Luckett, et al. 2011). The Symptoms Checklist 
Revised – 90 (SCL-90) is a 90-item checklist that is widely used in clinical settings to screen for 
psychopathology and psychological symptomology (Derogatis & Unger, 2010). It has been used 
with cancer patients to screen for both depression and anxiety reliably (α = .90) (Fafouti et al., 
2010) however is not specific to those constructs as it includes 7 other domains of distress and 
pathology (Derogatis & Unger, 2010). Similarly, the Patient Health Questionnaire (PHQ) is a 
screening instrument with sections addressing several domains of psychopathology and contains 
the PHQ-9, a nine-item section specifically relating to depressive symptoms from DSM criteria 
that has been found to reliably detect depression symptoms (α = 0.85) (Williams, et al. 2002). 
Both the SCL-90 and the PHQ are available in Spanish and have been found to have good 
validity and reliability when tested with Spanish speaking participants (α = 0.7-0.85 and α = 
0.72, respectively), though neither have been validated specifically with HNC and LC patients in 
published research highlighting a gap in the current literature (Huang et al., 2006; Vallejo et al., 
2007). Additionally, the PHQ-9 includes items that capture somatic symptoms that may overlap 
with depression or simply be related to illness, which is problematic for use with cancer patients 
(Luckett, et al., 2010). The Brief Symptoms Inventory (BSI-18) is widely used in cancer patients 
to screen for psychological distress and has normative data for cancer patients. It is one of the 
briefer yet thorough measures for psychological distress and has a three factor structure that has 
been validated in samples of breast cancer patients and Spanish speaking patients (α = 0.89) 




psychological subscales other than depression and anxiety and is costly to administer, making it 
less feasible than other options for screening depression (Luckett et al., 2010).  
Overall, the wide variety of measures being used to screen and detect depression make 
comparison across groups challenging. Beyond the issue of heterogeneity in measuring tools, 
instruments such as the HADS may not capture the spectrum of depression symptoms or be as 
sensitive to changes in patient outcomes (Luckett et al., 2011) and have not been validated 
specifically with LC or HNC patients. The need for standard assessment that reliably and validly 
capture patient distress in this population may be met by implementing a new set of measures, 
the Patient Reported Outcomes Measurement Information System or PROMIS. PROMIS was 
developed for the evaluation of the impact of chronic conditions on HRQoL as reported by the 
patient in a manner that is consistent, quick, free, and with improved clinical sensitivity (Ader, 
2007). Each scale in the PROMIS measures captures a different facet individual’s experiences of 
chronic illness and can be given in short versions for ease of use. PROMIS measures can be used 
by clinicians to compare across samples of participants due to the regulated structure and are 
desirable for research outcomes because of this. Under the mental health domain, PROMIS has 
two scales, one for depression and one for anxiety (National Institute of Health [NIH], 2007). 
The PROMIS Depression item bank includes diagnostic criteria that differentiates from other 
psychological issue and excludes somatic symptoms that would be impacted by health status. 
Additionally, the PROMIS measures were created to be inclusive, meaning that reading level 
required is lower in attempts to be more widely accessible to populations with lower literacy 
rates that do not exceed six grade reading levels (NIH, 2007). These measures are available in 
Spanish and when evaluated for validity and reliability have been found to be adequate tools for 





Beyond depression alone, a strong relationship between depressive episodes and anxiety 
has been found suggesting overlap between both psychological disorders in people with HNC 
and LC (Hopwood & Stephens, 2000; Zabora et al., 2001; Burgess, et al., 2005; Stafford, Judd, 
Gibson, Komiti, Mann, & Quinn, 2013; Hyphantis, Almyroudi, Paika, Degner, Carvalho, & 
Pavlidis, 2013). Anxiety is characterized by excessive anxiety or worry, apprehensive 
expectation, restlessness, irritability, muscle tension, sleep disturbance, fatigue, and difficulty 
concentrating (American Psychological Association, 2013). These symptoms must be interfering 
with functioning in multiple domains (social, occupational) and cause significant distress to be 
considered clinically relevant. Assessments of clinical anxiety therefore must include questions 
regarding symptomology and level of distress in order to determine the presence of clinical 
anxiety. A distinction can be made between state and trait anxiety, with state anxiety describing 
more transitory anxiety symptoms and trait anxiety referring to a more stable anxious demeanor 
(Endler & Kocovski, 2001).  Between these two types of anxiety, state anxiety has been found to 
be positively correlated with QoL in cancer patients and is most amenable to intervention 
(Hyphantis et al., 2013). While this difference can be relevant for tailoring interventions for 
patients, most measures do not distinguish between the two.  
General anxiety and depression symptoms have been found to be correlated with other 
negative outcomes beyond QoL such as lack of confidence and lack of intimate relationships 
indicating the importance of assessment and treatment (Stafford et al., 2013). Rates of anxiety 
and depression were found to be more related to patient factors (i.e. SES, education, social 
support, etc.) than factors of treatment or diagnosis (Burgess et al., 2005, Stafford et al., 2013), 




psychosocial variables. The prevalence of anxiety symptoms may be slightly lower than 
depressive symptoms in LC and HNC patients, however the prevalence at which anxiety and 
depression co-occur is highest, again indicating the importance of assessing for these symptoms 
(Hammerlid et al., 2001; Hutter, Vogel, Alexander, Baumeister, Helmes, & Bengel, 2013). 
Moreover, high correlations have been found between symptoms of anxiety and problems in 
family relationships, pain and fatigue, maladaptive problem solving and conflict management 
(Lueboonthavatchai, 2007). Untreated, anxiety symptoms may negatively impact the patients’ 
survival rates, emotional functioning, and economic burden, indicating that detection of these 
symptoms is important for positive outcomes (Stafford et al., 2013; Hutter et al., 2013). 
Rates of depression and anxiety in LC and HNC patients appear to be higher for 
medically underserved populations (HHS, 2001; Aneshensel, 2009; Ell et al., 2005; Luckett et 
al., 2011; Loi et al., 2013). Mental health disparities in this population reflect higher 
psychological needs and fewer resources to address these needs fully (Burke, Miller, Saad, 
Abraham, 2009; Forrest et al., 2013). Studies with Latina cancer patients have found that higher 
levels of stress and anxiety are related to lower levels of social and emotional support from 
friends and family, indicating there may be a reciprocal relationship between distress and social 
support, that more distress early on erodes social support in subsequent months (Alferi et al., 
2001; Lopez‐Class, Gomez‐Duarte, Graves, & Ashing‐Giwa, 2012; Gonzalez et al., 2015). 
Because social support has been researched as a correlate with positive outcomes, it is 
concerning that social support decreases in samples of underserved patients. Another study 
indicated that anxiety and other symptoms of psychological distress in underserved cancer 
patients impacted the psychological distress of their supportive partners to the extent that the 




1985; Nijboer et al., 1998; Segrin & Badger, 2013). These findings highlight the damaging 
outcomes of mental distress in underserved cancer patients, indicating not only higher rates of 
distress in this population but higher likelihood of lasting negative outcomes on social support 
partners, which leads to poorer support for the patient.  
Measures of Anxiety 
To screen for anxiety symptoms, like depressive symptoms, there is a variety of measures 
commonly used in the field that vary from global psychological distress measures to anxiety 
specific tools. As previously mentioned, the HADS, PHQ, SCL-90, and BSI can be used for 
depressive symptoms as well as anxiety symptoms and have Spanish versions available that have 
undergone reliability and validity assessments in Spanish speaking populations (Schroevers et 
al., 2000; Zabora et al., 2001; Williams et al., 2002; Mitchell, Meader, & Symonds, 2010; 
Derogatis & Unger, 2010; Reyes-Gibby et al., 2012; Stafford et al., 2013).  For anxiety specific 
measures, many options exist as well, although few have been used with underserved cancer 
patients or validated with that population. The Generalized Anxiety Disorder Screener (GAD-7) 
is a seven item self-report anxiety questionnaire that assesses generalized anxiety symptoms (α = 
0.89) but also has been used to detect social anxiety, panic, and post-traumatic stress disorder 
symptoms in primary care and cancer patients indicating its tendency to capture symptoms 
beyond general anxiety (Lowe et al., 2008; Brown et al., 2010). A cultural adaptation of the 
GAD-7 for Spanish speakers is available but has not been used in cancer specific populations 
(Garcia-Campayo, 2010). 
 The State Trait Anxiety Inventory (STAI) is a 40-item measure (20 items per subscale) 
that examines the presence and severity of anxiety symptoms, both transitory and long lasting 




0.95), though somewhat poor ability to distinguish between anxiety and depression (Spielberger, 
1983; Kennedy, Schwab, Morris, & Beldia, 2001; Julian, 2011). The STAI is available in 
Spanish though has not been used with HNC and LC cancer patients specifically. Additionally, 
the STAI is designed to distinguish between state and trait anxiety symptoms and does not 
correlate with diagnostic criteria (Julian, 2011). The Beck Anxiety Inventory (BAI) is a 21 item 
self-report measure designed to capture symptoms of anxiety distinct from overlapping 
depression symptoms and has been shown to have high internal consistency reliability (α = 0.94) 
(Leyfer, Ruberg, & Woodruff-Borden, 2006). The BAI is available in Spanish (Magan, Sanz, & 
Garcia-Vera, 2008) but has not been validated HNC and LC patients and requires 21 items to 
establish cutoffs for anxiety which may be lengthy when combined with other measures.  
These measures of anxiety capture the construct of anxiousness however do not correlate 
directly with diagnostic criteria for anxiety, have not been used with underserved HNC and LC 
patients, and may capture information beyond what is necessary for screening for anxiety, 
creating unnecessary burden by added length.  Overall, significant overlap is present in measures 
looking at anxiety and depression, and as with assessments of depression, a gap in the literature 
exists for assessment of these symptoms in LC and HNC patients. The use of the PROMIS 
anxiety subscale addresses fear, anxious misery, hyperarousal, and somatic symptoms that relate 
to arousal, which are differentiating items between anxiety and threat response (NIH, 2007). 
These items do not capture behavioral avoidance or other anxious correlates but focus on the 
fewest number of items needed to detect anxiety (NIH, 2007). In doing so, the PROMIS 
measures emerge as a more succinct and reliable way of measuring anxiety symptoms (α= 0.90-




patients. The current study sought to establish validity and reliability of the PROMIS measures 
for use in this population of LC and HNC patients.  
Quality of Life 
An important construct discussed in research regarding illness and its impact on the 
patient is QoL measures. QoL as a construct includes physical, mental, emotional, spiritual, 
functional and social functioning (Ashing-Giwa & Lim, 2009). Health related quality of life 
(HRQoL) examines the aforementioned variables as they are impacted by health status, such as 
chronic illness or disability (US Dept. Health and Human Services, 2014). Cancer patients often 
experience decreased QoL, which may be related to high prevalence of depression, low 
socioeconomic status, and persistent life challenges within this population (Reich, Lesur, & 
Perdrizet-Chevallier, 2008; Ashing-Giwa & Lim, 2009). Compared to other cancer patients, 
highest pain rates were reported by LC and HNC patients (Sugimura & Yang, 2006). LC and 
HNC patients also experience high rates of post-treatment distress relating to disfigurement, 
illness, and mental health distress (Burke, Miller, Saad, & Abraham, 2009). A study by Hutter et 
al. (2013) investigated the relationship between quality of life and psychosocial variables in first 
time cancer patients, found that those with low QoL scores reported more depression, anxiety, 
anger, hostility, and general emotional distress. Social support appears to be a major predictor of 
depression, anxiety, and is measured by many QoL assessments (Lueboonthavatchai, 2007). 
Underserved patients tend to have lower reported social support and fewer financial resources, 
which is predicted to lead to less favorable outcomes (Ashing-Giwa, Tejero, Kim, Padilla, & 
Hellemann, 2007).   
Research on QoL and health related QoL among underserved patients has been somewhat 




al., 2007, Janz et al., 2009) and others reporting no significant differences based on medically 
underserved status (Ganz, Kwan, Stanton, Krupnick, Rowland, Meyerowitz, et al., 2004). More 
valid and reliable measurement methods may allow this connection to become clearer and 
highlight areas of improvement for researchers to address.  
Measures of Quality of Life 
The assessment tools that have been used more widely for QoL include the Functional 
Assessment of Cancer Therapy (FACT-General, FACT-L for lung cancer specific, FACT-HN 
for head and neck cancer specific), the Satisfaction with Life Domains Scale for Cancer (SLDS-
C), and the World Health Organization Quality of Life Scale (WHOQOL). The FACT-G is a 28 
item scale developed for assessment of QoL in patients undergoing general cancer treatment with 
strong internal reliability (α = 0.90) (Cella et al., 1993). The measure includes sections on 
physical, functional, social, and emotional well-being, as well as a section addressing satisfaction 
with the treatment relationship with medical providers (Cella et al., 1993). The FACT-G is 
available in Spanish and has been evaluated for reliability and validity with Uruguayan patients 
with strong results (α = 0.78-0.91) (Dapueto, et al., 2003). The FACT-L was found to be valid 
and reliable among LC patients (α = 0.68-0.89) and FACT-HN to be valid and reliable among 
HN patients (α = 0.74- 0.86). The SLDS-C uses response format of seven smiling faces and 
seven frowning faces in order to assess QoL in cancer patients (Baker, 2014). It is particularly 
useful for individuals with low literacy due to its simpler wording and picture-based response 
format. The WHOQOL-100 consists of 100 items was developed with the goal of cross-cultural 
relevance in QoL assessment and was been piloted in 15 different cultural settings and 12 
different languages, including Spanish (α= 0.90) (Group, 1998). Due to its length which lowers 




items, is available in 12 languages, and has comparable psychometric properties as the full 
version (r = 0.90) (Skevington, Lotfy, & O'Connell, 2004).  
With the exception of the WHOQOL, other assessments have not been developed with a 
consideration of cultural relevance or consideration. PROMIS measures of QoL include social 
functioning, ability to participate in social roles, measures of physical health, and self-efficacy 
which may capture more culturally salient experiences. As stated, the PROMIS measures were 
created in an effort to reduce burden of time and mental capacity on the patient, allowing for 
more effective assessment. The measures mentioned prior to the PROMIS measures may provide 
a comprehensive picture of the experience of QoL among HNC and LC patients, however for 
purposes of comparison across studies it would be useful for one concise measure to be used 
consistently and to be established as valid and reliable in populations of underserved LC and 
HNC patients specifically. These discrepancies may be related to discrepancies in how QoL is 
measured and assessed, one meta-analysis stating that no single instrument was used in more 
than 10% of the studies, indicating the further the need for consistency in assessment tools 
(Mandelblatt et al., 2004). 
PROMIS Measures  
PROMIS is the product of an NIH roadmap project to improve patient reported outcomes 
by developing items that are sensitive to change and inclusive of many domains relevant to the 
experience of chronic illness. The PROMIS measures have been gaining acceptance and are 
becoming the clinical standard measurement protocol for research institutions such as the NIH 
and the Patient Centered Outcomes Research Institute (PCORI).  PROMIS measures were 
developed using Item Response Theory (IRT) and Computerized Adaptive Testing (CAT). These 




taken from input of hundreds of experts as well as national and international organizations in the 
“health” field including physical, mental, and social domains. Questions in each domain were 
generated and then analyzed via IRT in order to construct unidimensional domains that are 
mutually exclusive and exhaustive. Items that were redundant or not domain specific were left 
out of the final item bank, allowing quick and easy testing. To further reduce the difficulty and 
amount of time for patients, CAT allows for screening questions that reduce domain specific 
items based on individual’s responses to the screening question (Fries, Bruce, & Cella, 2005). 
Ongoing and rigorous measures of content and concurrent validity are tested as well to ensure 
the items are accurate representations of the constructs intended to be measured (Riley, Pilkonis, 
& Cella, 2011). The PROMIS measures include eight profile domains and fifteen additional 
domains that were normed on a sample matched demographically to the U.S. Census data from 
2007, with 12.5% of participants identifying as Latino/Hispanic (Cella, et al., 2010). The 
PROMIS measures have been found to have comparable psychometrics as with non-Hispanic 
white and English speaking populations, indicating their usefulness for this study (Paz, Spritzer, 
Morales, & Hays, 2013; Hahn et al., 2014; Viligut, et al., 2015). The number of items 
administered is flexible and adaptable in terms of number of questions and content based on 
researcher preference and CAT data (National Institutes of Health, 2013). For example, domains 
that are not applicable to a certain individual can be omitted, allowing for more succinct testing. 
The domain of emotional distress includes scales relating to symptoms of both anxiety 
and depression that correlate to DSM 5 diagnostic criteria, however exclude the somatic 
symptoms mentioned in DSM 5 (Riley, Pilkonis, & Cella, 2011). This exclusion is based on the 
overlap between somatic symptoms and other effects of illness as well as the notion that somatic 




pure anxiety or depression states (Riley, Pilkonis, & Cella, 2011; Clarke & Kuhl, 2014). The 
usefulness of the PROMIS measures in detecting depression and anxiety as defined by DSM 5 is 
unique compared to many of measures commonly used in assessment in cancer patients. 
Current Study 
In the current study a battery of assessments measuring depression, anxiety, and QOL 
were administered to a sample of underserved HNC and LC patients as part of a larger 
intervention study. Participants were identified as underserved based on their self-reported SES 
and level of insurance coverage. Results of the survey responses were analyzed for internal 
consistency reliability, predictive validity, as well as convergent and divergent validity. Many 
assessment tools have been used to assess these concepts in other patients that do not correlate 
with clinical indices of these disorders and symptoms. For proper diagnosis and care, standard 
measurement across agencies and domains is needed. To better understand the mental health 
disparity gap in LC and HNC patients and collect data that is useful, it is necessary to establish 
whether valid and reliable measures of these factors exist.  
Depression, anxiety, and quality of life are important mental health indicators of the 
experience of underserved HNC and LC patients as discussed and must be measured in ways that 
create low level burden for patients and provide information that is clinically valid and useful. As 
evidenced by the literature, several measures are commonly used to assess these constructs but 
are not consistent used across studies. To establish a more standard measure of these mental 
health constructs in LC and HNC patients the PROMIS measures are proposed as better and 










Participants were consented to the study as part of a larger longitudinal study examining 
psychological distress interventions in HNC and LC patients. All participants were recruited at 
one of four hospitals in Northern Colorado (Denver Health Medical Center, Saint Mary’s 
Medical Center, Saint Joseph Hospital, and National Jewish Health) and eligibility for 
participation was determined by baseline assessment of eligibility criteria. Inclusion criteria 
included those who were: over 18 years old, English or Spanish speaking, low income (below the 
Federal poverty line) or uninsured/underinsured, and newly diagnosed (within one month from 
first oncology appointment). Participants were either emailed links to the survey to complete the 
surveys online or mailed paper versions that were then mailed in and entered by the research 
team, depending on patient preference. The survey included demographic information (Appendix 
A and Appendix B), the PROMIS measures, the HADS, the FACT-L and FACT-HN 
(Appendices C-L) in addition to a measure of perceived stress and a measure of coping skills that 
were not analyzed as part of the current study. Each participant received a $25 gift card 
following completion of the survey.  
All procedures and methods employed throughout the study were approved through the 
Colorado Multiple Institutional Review Board (Protocol # 16-2621) on March 17, 2017 and 
given continuing review approval on March 6, 2018. Patient information was entered into a 
password protected database and all study materials were kept in a secure and locked facility in 





There were 93 LC and/or HNC patients who were consented to participate in the study. 
One participant did not complete the survey past the demographic information, therefore 92 
participants completed the survey. Of those 92, there were 64% who self-identified as males and 
36% who self-identified as females, ranging in age from 43-87 years of age (M = 65.93, SD = 
9.34). Regarding primary racial background 84% of the participants self-identified as White, 6% 
as Black, 1% as Asian and 7% declined to answer. When asked to self-identify their primary 
ethnic background, 80% of participants identified as non-Hispanic and 19% identified as 
Hispanic. Of the participants, 88 individuals indicated English as their preferred language and 4 
indicated Spanish as their preferred language; participants were administered surveys in their 
preferred language (See Table 1 for demographic statistics). 
 Diagnoses of women with these cancers is on the rise while male rates of diagnosis have 
stabilized in underserved patients, suggesting that this sample may not be representative of 
underserved HNC and LC patients in the larger population (Saba et al. 2011). Additionally, 
underserved and underinsured patients nationally tend to be more ethnically and racially diverse 
than what was collected for this sample (Anderson, et al. 2004; Ward, et al. 2004). The 
demographic information of this sample is not typical of underserved HNC and LC patients from 
other studies conducted on this population. Furthermore, the hospitals in this study were largely 
in urban areas and likely did not reach participants living and receiving treatment in more rural 
areas, impacting the representativeness of the sample.  
Power Analysis 
An observed power analysis was conducted using the software package GPower (Faul & 




and determined that a minimum of 82 participants were needed to achieve 80% power (critical z 
= 1.644). The post-hoc power analysis was conducted and demonstrated that with N=92 (one-
tailed z-test, odds ratio of 1.2, p< .05), observed power was equal to 0.85. Based on this analysis, 
enough participants were part of the study to find significance in both the correlational analyses 
and logistic regression.  
Measures 
PROMIS. PROMIS was developed by a National Institute of Health roadmap initiative 
to provide a more streamlined evaluation of impact of chronic conditions on HRQoL. PROMIS 
measures have been normed and validated using a sample of individuals with a variety of self-
reported chronic illness via YouGovPoll. They include measures of global health, physical 
health, mental health, and social health and both short and long versions of each domain. The 
items require low literacy levels, leading to more accessibility and applicability to populations 
with lower education levels. PROMIS measures correlate with clinical domains of psychological 
disorders from the DSM 5. The PROMIS system is considered a mature instrument because of 
continued modification relating to studies in diverse clinical populations. (Fries, Bruce, & Cella, 
2005). PROMIS measures are scored on a T-score metric (µ = 50, SD = 10) and is referenced to 
the US general population (2007 Census).  
The NIH has also developed the PROMIS-Ca that includes additional items related to 
physical functioning and is designed to be used with any kind of cancer. The PROMIS-Ca 
measure has different calibrations from the standard adult measure and is not available in a short 
form yet (NIH, 2015).  PROMIS measures provide a variety of form lengths to choose from 
including the full item banks (between 50 and 55 items per subscale), broad profile assessments 




The profiles provide a dimensional picture of HRQoL and include the subscales for depression 
and anxiety (NIH, 2007). For the purpose of this study, the 30-item depression and the 23-item 
anxiety subscale will be administered, in an effort to capture the full picture of psychological 
distress while also reducing participant burden. All PROMIS scales have been translated to 
Spanish, except the sexual functioning domain. PROMIS measures have been used with samples 
of patients with cancer (Cella, et al., 2014; Paz, Spritzer, Morales, & Hays, 2013; Badger, 
Heitkemper, Lee, & Bruner, 2014; Hahn, et al., 2014; NIH, 2015; Viligut, et al., 2015), however 
they have not been used specifically with underserved LC and HNC patients in published 
research for evaluations of validity and reliability. The PROMIS Anxiety displayed good 
convergent validity with a historical assessment of anxiety, the Mood and Symptom Anxiety 
Questionnaire (α= .81) and PROMIS Depression exhibited good convergent validity as well with 
the CESD (α= .84) (NIH, 2013). The ability of the PROMIS measures to predict presence of 
anxiety and depression was assessed by determining the ability of the PROMIS measures to 
predict group membership into those participants who identified as having been previously 
diagnosed with either an anxiety disorder or depressive disorder prior to participation in the 
study.  
HADS. To assess for convergent validity of the PROMIS measures, the Hospital Anxiety 
and Depression Scale (HADS) was given to participants and was expected to be highly 
correlated with the PROMIS measures for depression and anxiety. The Hospital Anxiety and 
Depression Scale is a 14-item questionnaire broken up into two subscales, the HADS-A for 
anxiety and the HADS-D for depression. Responses are self-scored from 0-3, 3 indicating more 
severe symptoms. The HADS has been found to have high internal consistency and sensitivity to 




validity with longer and more establishes scales such as the BAI, BDI, and SCL-90 (α = .6-.8). 
On average, the HADS takes patients between 2-5 minutes. (Bjelland, Dahl, Haug, & 
Neckelmann, 2002). The HADS and PROMIS measures have been correlated (Yost, Eton, 
Garcia, & Cella 2011) with results indicating high levels of relatedness, however the two 
measures have not yet been compared in samples of LC and HNC patients. 
FACT. In addition to the HADS, the FACT-L, and FACT-HN was also administered to 
participants and expected to differ from scores on the PROMIS, to determine divergent validity.  
The FACT assesses health related quality of life measures specific to cancer patients which 
should differ from constructs of anxiety and depression, captured by PROMIS. The assessment is 
a valid and reliable 48-item health related quality-of-life questionnaire with high internal 
consistency (α  = .90) and high levels of test-retest reliability, as well as convergent and 
divergent validity (Brady, Cella, Mo, Bonomi, Tulsky, Lloyd, & Shiomoto, 1997). Domains 
assessed are physical, functional, social and family, and emotional well-being (Dapueto, et al., 
2003; Ell et al., 2005). The FACT-L and FACT-HN include the FACT-G and 20 items 
addressing the individual concerns of the specific cancer, with FACT-L retaining 8 additional 









All data was examined for missing cases. Data that reflected patterns of error, for 
example skipping one of the measures entirely or not reporting cancer status, was discarded so 1 
case was removed. Analyses began with assessing the reliability via Cronbach’s alpha of the 
PROMIS, FACT, and HADS measures. Reliability for the PROMIS scale were assessed 
separately for each subscale, the 30-item depression subscale and 23-item anxiety subscale were 
both found to have acceptable reliability (see Table 2 for all reliability statistics). The 35-item 
FACT-L, 39-item FACT-HN and 14-item HADS scales. Histograms were run on the PROMIS, 
FACT, and HADS and revealed a pattern of positive skew.  All three measures were somewhat 
positively skewed but determined to be within the acceptable limits as demonstrated by skew and 
kurtosis being inside the limits of -1 to 1 (see Table 2).  
 Although a confirmatory factor analysis (CFA) was proposed to confirm the factor 
structure of the PROMIS measure with this population, the sample size of the current study did 
not meet the necessary minimum of participants required to run this analysis. It is recommended 
that at least 200 participants (Hoelter, 1983) or a minimum of 5-10 participants per item (Floyd 
and Whidaman, 1995), neither of which were met. Analysis that require less participants were 
used to further explore the validity of the PROMIS measure. 
 Reliability. Analysis using Cronbach’s Alpha Test was used to test the internal 
consistency reliability of the three scales included in the study. Reliability for the total PROMIS 
scale, as well for the depression and anxiety subscales separately was found to be highly reliable 
(α= 0.97, α = 0.97, and α = 0.98 respectively). Reliability for the HADS (α= 0.88) and FACT (α= 




Validity. Convergent validity was determined by computing Pearson’s product moment 
correlation coefficients to understand the strength and relationship between the PROMIS and 
HADS. Table 3 shows the means, standard deviations and intercorrelations for all scales.  
Specifically, strong positive correlations between the overall PROMIS score and overall HADS 
score (r= 0.76, p<.01), between PROMIS anxiety subscale and HADS anxiety subscale (r=0.78, 
p<.01), and between the PROMIS depression subscale and HADS depression subscale (r=0.59, 
p<.01). This finding demonstrates that PROMIS scores and HADS scores are capturing the same 
constructs of depression and anxiety within this sample of participants. Discriminant validity was 
also investigated using Pearson’s product moment correlation coefficients. Non-significant 
negative correlations were observed between the overall PROMIS score and the FACT-HN (r=-
0.21, p= 0.4) and the FACT-L (r=-0.26, p= 0.19) indicating that the PROMIS measures and 
FACT-HN and FACT-L were possibly not capturing the same construct (See Table 4). 
In order to test predictive validity of the PROMIS assessment in this population, logistic 
regression analysis methods was used to investigate whether self-reported psychological 
diagnosis can be predicted by scores on the PROMIS by regressing group membership 
(dichotomous yes/no responses to the question “Have you been diagnosed with a depressive 
disorder?” or “Have you been diagnosed with an anxiety disorder?”) on PROMIS depression 
anxiety scores subscale scores. The dependent variable of psychological disorder was coded such 
that 0= no anxiety disorder diagnosed previously and 1= previous diagnosis of an anxiety 
disorder for one item in the regression and 0 = no depressive disorder diagnosed previously and 1 
= previous diagnosis of a depressive disorder for the second item in the analysis. Assumptions of 
logistic regression were tested for the analyses. No evidence of multicollinearity was found 




acceptable range) and assumptions of independence of errors and linearity were also met (Field, 
2009).  
A test of the PROMIS depression model against a constant only model was statistically 
significant, indicating that the PROMIS depression items as a set reliably distinguished between 
those who were previously diagnosed with a depressive disorder and those who were not (chi 
square = 19.550, p < .001, df = 1). Nagelkerke’s R2 of .334 indicated a small relationship 
between predictor and grouping. Prediction success overall was 89.1% and the Wald criterion 
demonstrated that the PROMIS depression scale is a small but significant contribution to 
prediction of depressive disorder (p < .001). Exp(B) value indicates that when PROMIS 
depression score is raised by one unit (one point on the scale) the odds ratio is 1.12 times as large 
(See Tables 5 and 6).  
Similarly, a test of the PROMIS anxiety model against a constant only model was 
statistically significant, indicating that the PROMIS anxiety items as a set reliably distinguished 
between those who were previously diagnosed with an anxiety disorder and those who were not 
(chi square = 4.775, p < .05, df = 1). Nagelkerke’s R2 of .113 indicated a very small relationship 
between predictor and grouping. Prediction success overall was 89.1% and the Wald criterion 
demonstrated that the PROMIS anxiety scale is a small but significant contribution to prediction 
of depressive disorder (p < .001). Exp(B) value indicates that when PROMIS anxiety score is 








The purpose of this project was to examine the reliability and validity of the PROMIS 
measures in a sample of underserved, low-income, under-insured head, neck, and lung cancer 
patients. The PROMIS measures were found to be valid and reliable with the study's sample of 
LC and HNC patients from four hospitals in Colorado. More specifically, when compared to the 
HADS, the PROMIS measures demonstrated high convergent validity and adequately captured 
the domains of depression and anxiety symptoms in this sample. When compared to the FACT, 
the PROMIS scores were inversely related, indicating that the two measures are likely capturing 
distinct constructs thus demonstrating discriminant validity for the PROMIS measures. The 
relationship between FACT and PROMIS measures was nonsignificant, possibly due to sample 
size of those participants who completed each version (lung or head and neck versions were split 
into two groups), reducing the overall sample size for comparison.  
PROMIS Measures 
To understand how PROMIS measures capture the experience of LC and HNC patients, 
measures from different domains related to psychological outcomes were included in the study. 
The investigation revealed that the PROMIS measures were positively correlated with scores on 
the HADS, which was anticipated based on the literature indicating the overlap in content of the 
scales. Depression and anxiety subscales from the PROMIS were strongly and positively 
correlated with the respective subscales on the HADS, and overall scores from both measures 
were also positively correlated. Discriminant validity was demonstrated by exploring the 
relationship between the PROMIS measures and a health-related quality of life measure, the 




cancer were included in the study to capture the unique experience of these patients. The 
relationship between the PROMIS and the FACT scores was negative and nonsignificant, 
supporting the hypothesis that the measures are capturing separate constructs and measuring 
distinct aspects of the impacts of cancer.  
Although validity and reliability for the PROMIS measures was established using the 
measures included, not enough participants utilized the Spanish version of the survey to make 
comparisons regarding translation. Conclusions could have been drawn about the Spanish 
translation of PROMIS measures for LC and HNC patients had the sample been more variable in 
language proficiency. The PROMIS measures also included several subscales that assessed 
cancer related distress and quality of life domains that could have been added and compared to 
existing measures of HRQoL. Though inclusion of these additional subscales would increase the 
number of items administered, it may have provided a broader picture of the distress that is 
experienced by LC and HNC patients. More information on the distinct aspects of distress 
endured by patients could have better informed interventions and treatment as part of the larger 
intervention study. The depression and anxiety subscales, however, did prove to be valid 
measures of psychological distress in the sample of underserved LC and HNC patients surveyed 
in this study. 
To understand the power of the PROMIS measures to predict psychological distress, a 
logistic regression was conducted. Findings indicated that the PROMIS measures increase the 
probability of predicting the presence of a psychological disorder in the participants. Based on 
the literature, the PROMIS measures are expected to significantly predict psychological distress. 
However, items used in the logistic regression for the current study were chosen based on the 




question in the survey asked participants whether they had ever previously been diagnosed with a 
depressive or anxious disorder. Because this information was taken from the baseline survey in 
the study, the implication was that this diagnosis would have taken place prior to cancer 
diagnosis and treatment. PROMIS measures are designed to capture the distress related to the 
cancer experience and therefore are not directly addressing the question posed in the 
demographic question section. A change in methodology such as including a second time point 
at which participants are asked whether they meet criteria for an anxious or depressive disorder 
post-diagnosis and treatment would better demonstrate the predictive validity of the PROMIS 
measure and possibly lead to a more significant effect in the regression equation.  
Additional analyses were proposed to confirm that the factor structure found in the 
PROMIS measures when administered to the normed sample matched the factor structure 
observed within responses of the current sample. However. these analyses require a higher 
number of participants than what was recruited at the time of analysis and consequently, the 
confirmatory factor analysis was not conducted. 
Implications and Contributions 
 Through this study, PROMIS anxiety and depression subscales were determined to be 
valid and reliable measures of psychological distress in a sample of underserved LC and HNC 
patients. The PROMIS measures were designed to be straight forward, domain specific, and 
correlated to DSM-5 criteria of diagnosis in both English and Spanish versions for cancer 
patients in general (Riley, Pilkonis, & Cella, 2011). The current study is the first to utilize these 
measures with this specific population of LC and HNC who do not receive medical access at the 




PROMIS measures with diverse groups of patients and demonstrates its efficacy in detecting 
patients in mental distress. 
Interventions that target mental distress and symptomology in cancer patients are 
increasing in number as understanding of the relationship between distress and health outcomes 
continues to grow (Lopez‐Class, Gomez‐Duarte, Graves, & Ashing‐Giwa, 2012; Gonzalez et al., 
2015). Identification of patients who are struggling with psychological symptoms can lead to 
early mental health interventions, reducing negative outcomes such as increase in symptom 
severity, distress, and mortality rates. As part of a larger intervention study, the current project 
sought to inform the interventions used later with participants by licensed mental health 
professionals. By establishing PROMIS measures as valid and reliable, the current study may 
contribute to the successes of the overall intervention designed to reduce the mental distress 
experienced by underserved and underinsured HNC and LC patients.  
Future Directions 
Future studies should seek to direct more attention to recruitment and retention efforts to 
ensure that eligible participants are able and comfortable contributing to the knowledge base of 
this field. Gathering information from groups who are traditionally underserved can often present 
challenges that lead to exclusion from larger research studies (Shavers, Lynch, & Burmeister, 
2002). Reasons for this lack of inclusion have been reported to include: lack of patient awareness 
of the benefit of participation, poor patient well-being, poor physician/researcher and patient 
relationships, lack of institutional support, low literacy of patients , and lack of understanding of 
the nature of the project that leads to fear or concern about safety and/or confidentiality  (Sygna, 
Johansen, & Ruland, 2015; Bower, et al. 2014; Denicoff, et al. 2013). Studies on recruitment and 




study and ways participation can help others, increased advertising, an emphasis on development 
of culturally sensitive study materials, and recruitment of physicians and research team members 
who reflect patient population of underserved and minority identities (Sygna et al., 2015; Bower, 
et al. 2014; Denicoff, et al. 2013). Future studies should seek to focus on these areas because 
without research to inform treatment interventions, the concerns of underserved patients will not 
get addressed, furthering already existing health disparities. Continued efforts are needed to 
reach out to and treat those patients who are traditionally underserved and reduce the lack of 










Sample Demographic Characteristics 
Characteristic     N  Mean or %  Std. Deviation  
Female     32  34.4%    - 
Male      60  64.5%    -  
Age      93  65.93    9.34 
Hispanic     18  19.4%    - 
Non-Hispanic     75  80.6%    - 
Primarily English Speaker   89  95.7%    - 
Employed     22  23.7%    - 
Retired     50  53.8%    - 
Income less than $4,000 monthly  58  63%    - 
Income less than $8,000 monthly  13  15.2%    - 
More than $12,000 monthly   12  13.1%    - 
High school graduate    42  46.2%    - 
Some college     27  29.1%    - 
College graduate     8  8.6%    - 
Post-graduate     14  15.1%    -  
Private Insurance    37  40.2%    - 
Medicare     55  59.8%    - 
Medicaid     24  26.1%    - 






Reliability Statistics for PROMIS Scores 
Measure   Cronbach’s Alpha  Skewness  Kurtosis  
PROMISdep    .971   .859   -.436 
PROMISanx    .968   .752   -.207 







Pearson Correlations for Determining PROMIS Convergent Validity 
       PROMISdep         PROMISanx         PROMIStot             HADSdep       
PROMISdep 1  .812  .946  .593  .648  .701 
PROMISanx .812  1  .957  .508  .778  .733  
PROMIStot .946  .957  1  .576  .754  .755 
HADSdep .593  .508  .576  1  .567  .872 
HADSanx .648  .778  .754  .567  1  .898 







Pearson Correlations for Determining PROMIS Discriminant Validity 
  PROMIStot PROMISanx  PROMISdep FACTL  FACTHN   
PROMIStot 1  .957  .946  -.262  -.212 
PROMISanx .957  1  .812  -.181  -.095 
PROMISdep .946  .812  1  -.313  -.316 
FACTL -.262  -.181  -.313  1  - 






Do scores on the PROMIS predict patient-reported diagnosis of depressive disorders? Logistical 
Regression Analyses 
Source   B SE B  Wald χ2 p OR  
PROMIStotal  .117 .031  14.177  .000 1.124 






Do scores on the PROMIS predict patient-reported diagnosis of anxiety disorders? Logistical 
Regression Analyses 
Source   B SE B  Wald χ2 p OR  
PROMIStotal  .066 .031  4.547  .033 1.068 
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Section I: Personal Information 
First Name: 
Last Name: 
What is today’s date? 
What hospital are you associated with? 
o Denver Health 
o St. Joe’s 
o St. Mary’s 
o National Jewish 
How are you completing this survey? 
o Online 
o Paper and pencil 
o Phone call 
o Onsite  
What is your age in years? 




Are you currently pregnant? 









For “other”, what do you consider your primary ethnic background to be? 
Do you speak: 
o Only Spanish  
o Spanish better than English 
o Both Spanish and English equally well 
o English better than Spanish 
o Only English 
Do you read: 
o Only Spanish  
o Spanish better than English 




o English better than Spanish 
o Only English 
What is your current marital status? 




o Living partner 
o Widowed 
Are you now employed? 
o Yes 
o No 
Are you retired? 
o Yes 
o No 
For health insurance, do you have (check all that apply): 
o Medicare 
o Medicaid 
o VA coverage 
o Private Insurance 
Pick the category that best describes where your monthly income after taxes falls: 
o Less than $4000 
o Less than $5400 
o Less than $7100 
o Less than $8100 
o Less than $9500 
o Less than $10900 
o Less than $12300 
o Less than $13700 
o Less than $13701 
How many people in your household (including you) depend on your monthly income? 
What is the highest level of education you have completed? 
 
Section II: Cancer Diagnosis and Treatment Information 
Which is your primary cancer diagnosis? 
o Lung cancer 
o Head and neck cancer 
o Other 
For “other”, please list what your primary cancer diagnosis is, or indicate if “cancer of Unknown 
Primary” 
What is your secondary cancer diagnosis? 
o Lung cancer 
o Head and neck cancer 
o Other 




When were you first diagnosed with lung and/or head and neck cancer (pathologic tissue 
diagnosis)? 
o MM-DD-YYYY 




















When did you start your first cancer treatment (any treatment: surgery, chemotherapy, 
radiation)? 
o MM-DD-YYYY 





Section III: Behavioral Health Information 
Have you ever been diagnosed with a cognitive impairment such as (check all that apply): 
o Alzheimer’s or Dementia 
o Traumatic Brain Injury 
o Other 
o Never 
For “other” please describe 
 
Have you ever been diagnosed with any of the following? (Check all that apply) 
o Schizophrenia or psychotic disorder 
o Personality disorder (e.g. Borderline) 
o Intellectual disability (e.g. retardation)  
o Bipolar or related disorder 
o Depressive disorder 




o Trauma stressor disorder (e.g. PTSD) 
o Substance or addictive disorder 
o Other mental health disorder 
o Never  
For “other”, please list which mental disorders 
Have you ever taken a prescription drug (such as anti-depressants) for a mental condition in the 
past month? 
o Yes  
o No 




Have you sought social support services or resources related to your cancer diagnosis in the past 
month? 
o Yes, a cancer support group (in person or online) 
o Yes, information resources (e.g. websites, cancer associations) 
o Other 
o None 
How many times did you have six or more drinks on one occasion in the past month? 
o Never 
o Once a month 
o 2-4 times a month 
o 2-3 times a week 
o 4 or more times a week 
How often did you use “abusable” (e.g. prescriptions) or illegal drugs (e.g. cocaine) in the past 
month? 
o Never 
o Once a month 
o 2-4 times a month 
o 2-3 times a week 
o 4 or more times a week 
If you have smoked in the past month, how many cigarettes have you consumed a day? 
o Have not smoked in the past month 
o 1-10 cigarettes 
o 11-19 cigarettes 
o 20 or more cigarettes 
In the past month, did you smoke or use marijuana? 
o Yes, recreationally 
o Yes, for medical reasons 
o Yes, for both medical reasons and recreationally 
o No 





















Seccion I: Informacion Personal  
Primer nombre: 
Apellido: 
¿Cual es la fecha de hoy? 
¿Con cual hospital esta asociado? 
o Denver Health 
o St. Joe’s 
o St. Mary’s 
¿Como esta lienando este cuestionario? 
o En linea (correo electronico, telefono movil) 
o En la casa/papel y lapiz 
o Llamada por telefono 
o En el hospital 
¿Cual es sue dad? 
¿Cual es su sexo? 
o Masculino 
o Femenino  
o Otro 
¿Esta actualmente embarazada? 
o Si  
o No  









Para ‘Otro’, ¿cual consideras su perimer origen etnico? 
¿Que idioma habla? 
o Solo espanol 
o Espanol major que ingles 
o Tanto ingles como espanol 
o Ingles major que espanol 
o Solo ingles 
¿Usted sabe leer? 
o Solo espanol 
o Espanol major que ingles 
o Tanto ingles como espanol 




o Solo ingles 
¿Cual es su estado civil actual? 




o En pareja 
o Viudo/a 
¿Esta usted actualmente trabajando? 
o Si 
o No 
Para el Seguro de Sauld o medico, ¿tiene usted: 
o Medicare 
o Medicaid 
o Cobertura del VA 
o Seguro privado 
¿Que categoria se aproxima a su ingreso (despues de los impuestos, el total en cash) por mes? 
o Menos del $4000 
o Menos del $5400 
o Menos del $7100 
o Menos del $8100 
o Menos del $9500 
o Menos del $10900 
o Menos del $12300 
o Menos del $13700 
o Mas de $13701 








o 8 o mas 
Circule el nivel mas alto de educacion que has completado: 
o Grado de Escuela-1 
o Grado de Escuela-2 
o Grado de Escuela-3 
o Grado de Escuela-4 
o Grado de Escuela-5 
o Grado de Escuela-6 
o Grado de Escuela-7 
o Grado de Escuela-8 
o High school/secundaria-9 




o High school/secundaria-11 





o Anos de educacion despues de la graduacion universitaria-5 
o Anos de educacion despues de la graduacion universitaria-6 
o Anos de educacion despues de la graduacion universitaria-7 
o Anos de educacion despues de la graduacion universitaria-8+ 
 
Seccion II: Diagnositico y tratamiento del cancer 
¿Cual es su diagnostic de cancer primario? 
o Cancer de pulmon 
o Cancer de cabeza y cuello 
o Otro tipo de cancer 
Para ‘Otro tipo de cancer’, por favor liste cual fue su diagnostic de cancer primario o indique 
“Cancer de Origen Primario Desconocido”.  
¿Cual es su diagnostic de cancer secundario? 
o Cancer de pulmon 
o Cancer de cabeza y cuello 
o Otro tipo de cancer 
o No aplica 
Para ‘Otro tipo de cancer’, por favor liste cual fue su diagnostic de cancer secundario o indique 
“Cancer de Origen Primario Desconocido” 
¿Cuando fue diagnosticado por primera vez con su diagnostic primario (fecha cuando recibio el 
diagnostic de tejido patologico o biopsia)? 























¿Cuando comenzo su primer tratamiento contra el cancer (cualquiera de los tratamientos de 
cirugia, quimioterapia, o radiacion)? 






Seccion III: Informacion sobre la salud del comportamiento del paciente 
¿Le han diagnosticado un deterioro cognitvio como 
o Alzheimer o Demencia 
o Lesion cerebral traumatica 
o Otro 
o Nunca 
Para ‘otro’ por facor describalo 
¿Alguna vez le han diagnositcado alguna de las siguientes enfermedades? 
o Esquizofrenia o Trastorno Psicotico 
o Trastorno de la personalidad (limite o “borderline”) 
o Discapacidad intellectual (retardo mental) 
o Trastorno bipolar u otro relacionado 
o Trastorno depresivo 
o Trastorno de ansiedad 
o Trastorno de estres post-traumatico (PTSD) 
o Substancias o Adicciones 
o Otros Trastornos Mentales 
o Nunca 
Para ‘otros trastornos mentales’ por favor liste cuales trastornos 
¿Ha tomado medicamentos recetados (como antidespresivos) por una condicion mental en el 
ultimo mes? 
En caso que si, ¿que tipo de medicacion ha tomado? 
¿Ha participado activamente en consejeria o terapia por razones de comoramiento en el ultimo 
mes? 
¿Ha buscado servicios de apoyo o recursos relacionados con su diagnostic de cancer en el ultimo 
mes? 
¿Cuantas veces en una misma occasion bebio o mas bebidas alcoholicas en el ultimo mes? 
o Nunca 
o Una vez al mes 
o 2-4 veces al mes 
o 2-3 veces a la semana 
o 4 o mas veces a la semana 
¿Que tan seguido ha usado drogas recetadas (como medicinas) o ilegales (como cocaine) en el 
ultimo mes? 
o Nunca 
o Una vez al mes 




o 2-3 veces a la semana 
o 4 o mas veces a la semana 
Si usted ha fumado en el mes pasado, ¿cuantos cigarrilos ha consumido al dia? 
o No fumo en el ultimo mes 
o 1-10 cigarrillos 
o 11-19 cigarrillos 
o 20 o mas cigarillos 
En el mes pasado, ¿fumo o uso marihuana? 
o Si recreativamente 
o Si por razones medicinas 
o No 
¿Ha estado sin hogar (es decir, no tiene donde vivir) durante los ultimos 30 dias? 
o Si 
o No 




¿Ha pensado en hacerse un dano fisico o en terminar su vida en el ultimo mes? 
o Si  













PROMIS – 29 Profile v2.0 Items 
Please respond to each question or statement by marking one box per row.  
 Physical Function   
 
Are you able to do chores  
such as vacuuming or yardwork?             
(1) (2) (3) (4) (5) 
 
Are you able to go up and down 
stairs at a normal pace? 
(1) (2) (3) (4) (5) 
 
Are you able to go for a walk at least 15 minutes?   
(1) (2) (3) (4) (5) 
 
Are you able to run errands and shop?    




In the past 7 days… 
 
I felt fearful    1  2  3  4           5 
 
I found it hard to focus on  
anything other than my anxiety 1  2  3  4           5 
 
My worries overwhelmed me  1  2  3  4           5 
 




In the past 7 days…. 
 
I felt worthless   1  2  3  4          5 
 
I felt helpless    1  2  3  4          5 
 
I felt depressed   1  2  3  4          5 
 







During the past 7 days… 
 
I felt fatigued    1  2  3  4         5 
 
I have trouble starting things 
because I am tired   1  2  3  4         5 
 
In the past 7 days… 
 
How run down did you feel 
on average?    1  2  3  4         5 
 
How fatigued were you on 




In the past 7 days… 
 
My sleep quality was   5  4  3  2         1 
 
In the past 7 days… 
 
My sleep was refreshing  5  4  3  2         1 
 
I had a problem with my sleep 1  2  3  4         5 
 
I had difficulty falling asleep  1  2  3  4         5 
 
Ability to Participate in Social Roles and Activities 
 
I have trouble doing all of my regular leisure activities with others   
5  4  3  2           1 
 
I have trouble doing all of the family 
activities I want to do     
5  4  3  2     1 
 
I have trouble doing all of my usual work (include work at home)   
5  4  3  2                   1 
 
I have trouble doing all of the activities with friends that I want to do     







In the past 7 days… 
 
How much did pain interfere 
with your day to day activities? 1  2  3  4         5 
 
How much did pain interfere with  
work around the home?  1  2  3  4         5 
 
How much did pain interfere with 
your ability to participate in social  
activities?    1  2  3  4         5 
 
How much did pain interfere with 
your household chores?  1  2  3  4         5 
 
Pain Intensity 
In the past 7 days… 
 
How would you rate your pain on average?   











Appendix D  
PROMIS – 29 Profile v1.0 Items 
Spanish Version 
Responda a cada pregunta o enunciado marcando una casilla por linea.  
Capacidad de funcionamiento 
fisico 
    
 
¿Puede realizer tareas, como pasar 
la aspiradora o trabajar en el jardin?   5  4  3  2           1 
 
¿Puede subir y bajar escaleras a un 
paso normal?    5  4  3  2           1 
 
¿Puede salir a caminar durante 15 
minutos por los menos?  5  4  3  2           1 
 




En los ultimos 7 dias… 
 
Senti miedo    1  2  3  4           5 
 
Tuve dificultad para concentarme 
en otra cosa que no furera me  
ansiedad    1  2  3  4           5 
 
Mis inquietudes fueron demasiado 
para mi    1  2  3  4           5 
 




En los ultimos 7 dias… 
 
Senti que no valia nada  1  2  3  4          5 
 
Me senti indefenso/a (que 




ayudarme)    1  2  3  4          5 
 
Me senti deprimido/a   1  2  3  4          5 
 




En los ultimos 7 dias… 
 
Me siento agotado/a   1  2  3  4         5 
 
Tengo dificultad para comezar 
las cosas porque  estoy cansado/a 1  2  3  4         5 
 
En los ultimos 7 dias… 
 
¿Que tan rendido/a se sintio en 
promedio?    1  2  3  4         5 
 
¿Que tan agotado/a estuvo en 
promedio?    1  2  3  4         5 
 
Alteracion del sueno 
 
En los ultimos 7 dias … 
 
La caldidad de mi sueuno fue  5  4  3  2         1 
 
En los ultimos 7 dias… 
 
 
Mi sueno fue reparador  5  4  3  2         1 
 
Tuve problemas para dormir  1  2  3  4         5 
 
Tuve dificultad para dormirme 1  2  3  4         5 
 
Satisfaccion con la participacion en roles sociales 
 
 
En los ultimos 7 dias 
 
Estoy satisfecho/a con la cantidad  
de trabajo que puedo hacer 





Estoy satisfecho/a con mi capacidad 
para trabajar (incluya el trabajo en  
el hogar)    1  2  3  4         5 
 
Estoy satisfecho/a con mi capacidad 
para ocuparme de mis responsibilidades 
personales y domesticas regulares 1  2  3  4         5 
 
Estoy satisfecho/a con mi capacidad 
para desempenar mis activdades de rutina 
diarias     1  2  3  4         5 
 
Efectos del dolor 
 
En los ultimos 7 dias… 
 
¿En que medida el dolor interfirio 
En sus actividades diarias?  1  2  3  4         5 
 
¿En que medida el dolor interfirio en 
el trabajo en el hogar?   1  2  3  4         5 
 
¿En que medida el dolor interfirio en su 
capacidad para participar en actividades 
sociales?    1  2  3  4         5 
 
¿En que medida el dolor interfirio en sus 
tareas domesticas?   1  2  3  4         5 
 
Intensidad del dolor 
 
En los ultimos 7 dias… 
 
En promedio, ¿como calificaria su dolor?   







FACT-Head and Neck Cancer, Additional Concerns 
 
Please circle or mark one number per line to indicate your response as it applies to the past 7 
days.  
          
I am able to eat the foods that I like 
(0)Not at all (1) A little bit (2) Somewhat (3) Quite a bit (4) Very much 
My mouth is dry 
(0)Not at all (1) A little bit (2) Somewhat (3) Quite a bit (4) Very much 
I have trouble breathing  
(0)Not at all (1) A little bit (2) Somewhat (3) Quite a bit (4) Very much 
My voice has its usual quality and strength  
(0)Not at all (1) A little bit (2) Somewhat (3) Quite a bit (4) Very much 
I am able to eat as much food as I want 
(0)Not at all (1) A little bit (2) Somewhat (3) Quite a bit (4) Very much 
I am unhappy with how my face and neck look 
(0)Not at all (1) A little bit (2) Somewhat (3) Quite a bit (4) Very much  
I can swallow naturally and easily  
(0)Not at all (1) A little bit (2) Somewhat (3) Quite a bit (4) Very much 
I smoke cigarettes or other tobacco products 
(0)Not at all (1) A little bit (2) Somewhat (3) Quite a bit (4) Very much  
I drink alcohol (e.g. beer, wine, etc.) 
(0)Not at all (1) A little bit (2) Somewhat (3) Quite a bit (4) Very much 
I am able to communicate with others  
(0)Not at all (1) A little bit (2) Somewhat (3) Quite a bit (4) Very much 
I can eat solid foods 
(0)Not at all (1) A little bit (2) Somewhat (3) Quite a bit (4) Very much 
  
I have pain in my mouth, throat or neck  








FACT-Head and Neck Cancer, Additional Concerns- Spanish Version 
Marque un solo número por línea para indicar la respuesta que corresponde a los últimos 7 días.  
 
OTRAS PREOCUPACIONES   
Puedo comer lo que me gusta  
(0) Nada (1) Un poco (2) Algo (3) Mucho (4) Muchisimo 
Tengo la boca seca  
(0) Nada (1) Un poco (2) Algo (3) Mucho (4) Muchisimo  
Tengo dificultad para respirar  
(0) Nada (1) Un poco (2) Algo (3) Mucho (4) Muchisimo 
Mi voz sigue siendo la misma  
(0) Nada (1) Un poco (2) Algo (3) Mucho (4) Muchisimo 
Puedo comer cuanto quiera  
(0) Nada (1) Un poco (2) Algo (3) Mucho (4) Muchisimo  
Estoy descontento(a) con la manera en que lucen mi            
cara y mi cuello  
(0) Nada (1) Un poco (2) Algo (3) Mucho (4) Muchisimo 
Puedo tragar normalmente y sin dificultad  
(0) Nada (1) Un poco (2) Algo (3) Mucho (4) Muchisimo  
Fumo cigarros, cigarrillos (u otros productos derivados            
del tabaco)  
(0) Nada (1) Un poco (2) Algo (3) Mucho (4) Muchisimo  
Tomo bebidas alcohólicas (cerveza, vino, etc.)  
(0) Nada (1) Un poco (2) Algo (3) Mucho (4) Muchisimo 
Puedo comunicarme con los demás  







FACT-Lung Cancer, additional concerns 
 
I have been short of breath 
(0)Not at all (1) A little bit (2) Somewhat (3) Quite a bit (4) Very much 
I am losing weight 
(0)Not at all (1) A little bit (2) Somewhat (3) Quite a bit (4) Very much 
My thinking is clear  
(0)Not at all (1) A little bit (2) Somewhat (3) Quite a bit (4) Very much 
I have been coughing  
(0)Not at all (1) A little bit (2) Somewhat (3) Quite a bit (4) Very much 
I am bothered by hair loss  
(0)Not at all (1) A little bit (2) Somewhat (3) Quite a bit (4) Very much 
I have a good appetite  
(0)Not at all (1) A little bit (2) Somewhat (3) Quite a bit (4) Very much 
I feel tightness in my chest 
(0)Not at all (1) A little bit (2) Somewhat (3) Quite a bit (4) Very much 
Breathing is easy for me  
(0)Not at all (1) A little bit (2) Somewhat (3) Quite a bit (4) Very much 
Have you ever smoked?  
No ___  Yes ___  If yes:  
I regret my smoking  







FACT-Lung cáncer, additional concerns – Spanish Version 
 
Marque un solo número por línea para indicar la respuesta que corresponde a los últimos 7 días.  
  
OTRAS PREOCUPACIONES   
  
Me ha faltado el aire para respirar 
(0) Nada (1) Un poco (2) Algo (3) Mucho (4) Muchisimo 
Estoy bajando de peso  
(0) Nada (1) Un poco (2) Algo (3) Mucho (4) Muchisimo  
Pienso con claridad 
(0) Nada (1) Un poco (2) Algo (3) Mucho (4) Muchisimo 
He estado tosiendo  
(0) Nada (1) Un poco (2) Algo (3) Mucho (4) Muchisimo 
Me molesta la pérdida de cabello  
(0) Nada (1) Un poco (2) Algo (3) Mucho (4) Muchisimo 
Tengo buen apetito  
(0) Nada (1) Un poco (2) Algo (3) Mucho (4) Muchisimo 
Siento el pecho presionado  
(0) Nada (1) Un poco (2) Algo (3) Mucho (4) Muchisimo 
Respiro bien  
(0) Nada (1) Un poco (2) Algo (3) Mucho (4) Muchisimo 
¿Ha sido fumador(a)?  
No___   Sí___   En caso afirmativo:  
Me arrepiento de haber fumado 







Hospital Anxiety and Depression Scale 
 
Choose the reply that is closest to how you have been feeling in the past week.  Don’t take 
too long over your replies, your immediate answer is best.  
 
(A) 1. I feel tense or “wound up” 
3-Most of the time  
2-A lot of the time 
1-From time to time 





(D) 2. I still enjoy the things I used to enjoy 
0-Definitely as much 
1-Not quite so much 
2-Only a little 
3-Hardly at all 
 
(A) 3. I get a sort of frightened feeling as if something awful is about to happen 
3- Very definitely and quite badly 
2-Yes but not too badly 
1-A little, but it doesn’t worry me 
0-Not at all 
 
(D) 4. I can laugh and see the funny side of things  
0-As much as I always could 
1-Not quite so much now 
2-Definitely not so much now 
3-Not at all  
 
(A) 5. Worrying thoughts go through my mind 
3-A great deal of the time 
2-A lot of the time 
1-From time to time, but not too often 
0-Only occasionally 
 
(D) 6. I feel cheerful 
3-Not at all 
2- Not often 
1-Sometimes 
0-Most of the time 
 




3-Not at all 
 
(D) 8. I feel as if I am slowed down 
3-Nearly all of the time 
2-Very often 
1-Sometimes 
0-Not at all 
 
(A) 9. I get a sort of frightened feeling like “butterflies” in the stomach 






3- Very often 
 
(D) 10. I have lost interest in my appearance 
3-Definitely 
2-I don’t take as much care as I should 
1-I may not take quite as much care 
0-I take just as much care as ever 
 
(A) 11. I feel restless as if I have to be on the move 
3-Very much indeed 
2-Quite a lot  
1-Not very much 
0-Not at all 
 
(D) 12. I look forward with enjoyment to things 
0-As much as I ever did 
1-Rather less than I used to 
2-Definitely less than I used to 
3-Hardly at all 
 
(A) 13. I get sudden feelings of panic 
3-Very often indeed 
2-Quite often 
1-Not very often 
0-Not at all 
 






Total Score: (D) Depression    (A) Anxiety  
 
0-7 Normal Range 
8-10 Borderline Abnormal Range 







Hospital Anxiety and Depression Scale, Spanish Translation 
Translation Castresana, Perez, & de Rivera (1995) 
  
Este cuestionario ha sido diseñado para ayudarnos a saber cómo se siente usted. Lea cada 
frase y marque la respuesta que más se ajusta a como se sintió durante le semana pasada. 
No piense mucho las respuestas. Lo más segura es que si responde deprisa sus respuestas se 
ajustaran mucho más a como realmente se sintió.  
 
(A) Me siento tenso o nervioso 





(D) Todavía disfruto con lo que antes me gustaba 
0-Como siempre 
1-No lo bastante 
2-Solo un poco 
3-Nada 
 
(A) Tengo una sensación de miedo, como si algo horrible me fuera a suceder 
3- Definitivamente y es muy fuerte 
2-Si, pero no es muy fuerte 
1-Un poco, pero no me preocupa 
0-Nada 
 
(D) Puedo reírme y ver el lado divertido de las cosas  
0-Al igual que siempre lo hice 




(A) Tengo mi mente llena de preocupaciones 
3-La mayoría de las veces 
2-Con bastante frecuencia 
1-A veces, aunque no muy a menudo 
0-Solo en ocasiones 
 
(D) Me siento alegre 
3-Nunca 







(A) Puedo estar sentado confortablemente y sentirme relajado 
0-Siempre 
1-Por lo general 
2-No muy a menudo 
3-Nunca 
 
(D) Me siento como si cada día estuviera más lento 
3-Por lo general, en todo momento 




(A)Tengo una sensación extraña, como si tuviera mariposas en el estomago 
0-El nunca 
1-En ciertas ocasiones 
2-Con bastante frecuencia 
3- Muy a menudo 
 
(D) He perdido interés en mi aspecto personal 
3-Totalmente 
2-No me preocupe tanto como debiera 
1-Podria tener un poco más de cuidado 
0-Me preocupo al igual que siempre  
 






(D) Me siento optimista respecto al futuro 
0-Igual que siempre 
1-Menos de lo que acostumbraba 
2-Mucho menos de lo que acostumbraba 
3-Nada 
 
(A) Me asaltan sentimientos repentinos de pánico 
3-Muy frecuentemente 
2-Bastante a menudo 
1-No muy a menudo 
0-Rara vez 
 
(D) Me divierto con un buen libro, la radio, o un programa de televisión  
0-A menudo 
1-A veces 






Total Score: (D) Depression    (A) Anxiety  
 
0-7 Normal Range 
8-10 Borderline Abnormal Range 
11-21 Abnormal Range 
 
 
 
 
